Skip to content

Investigation of the Two Level Simplify® Cervical Artificial Disc

Clinical Study Protocol for the Investigation Of The Two Level Simplify® Cervical Artificial Disc

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03123549
Enrollment
182
Registered
2017-04-21
Start date
2017-04-01
Completion date
2022-03-24
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Degenerative Disc Disorder

Brief summary

This study is intended to demonstrate that the Simplify® Cervical Artificial Disc (Simplify® Disc) is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat two contiguous discs from C3 to C7 following discectomy at two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with neck pain or myelopathy due to abnormalities localized to the levels of the two contiguous disc spaces in subjects who are unresponsive to conservative management.

Detailed description

The objective of this clinical study is to evaluate the safety and effectiveness of the two-level Simplify® Disc compared to conventional two-level ACDF in skeletally mature patients for reconstruction of two contiguous discs from C3 to C7 following discectomy at two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with neck pain or myelopathy due to abnormalities localized to the levels of the two contiguous disc spaces that are unresponsive to conservative management.

Interventions

Simplify Disc at two levels of the cervical spine

Sponsors

NuVasive
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has cervical degenerative disc disease at two (2) adjacent cervical levels (from C3 C7) requiring surgical treatment and involving intractable radiculopathy, myelopathy, or both; * Has a herniated disc and/or osteophyte formation at each level to be treated that is producing symptomatic nerve root and/or spinal cord compression. The condition is documented by patient history (e.g., neck pain with arm pain, functional deficit and/or neurological deficit), and the requirement for surgical treatment is evidenced by radiographic studies (e.g., CT, MRI, x-rays, etc.); * Has been unresponsive to non-operative treatment for at least six weeks or has the presence of progressive symptoms or signs of nerve root/spinal cord compression in the face of continued non-operative management; * Has no previous surgical intervention at the involved levels or any subsequent planned/staged surgical procedure at the involved or adjacent level(s); * Must be at least 18 years of age and be skeletally mature at the time of surgery; * Has a preoperative Neck Disability Index (NDI) ≥ 30; * Has a preoperative neck pain score \> 8 based on the preoperative Neck and Arm Pain Questionnaire; * If a female of childbearing potential, patient is non-pregnant, non-nursing, and agrees not to become pregnant during the study period; * Is willing to comply with the study plan and sign the Patient Informed Consent Form.

Exclusion criteria

* Has a cervical spinal condition other than symptomatic cervical DDD requiring surgical treatment at the involved levels; * Has documented or diagnosed cervical instability relative to adjacent segments at either level, defined by dynamic (flexion/extension) radiographs showing: * Sagittal plane translation \> 3.5 mm, or * Sagittal plane angulation \> 20°; * Has more than two cervical levels requiring surgical treatment; * Has a fused level (or artificial disc replacement) adjacent to the levels to be treated; * Has severe pathology of the facet joints of the involved vertebral bodies; * Has had previous surgical intervention at either one or both of the involved levels or at adjacent levels; * Axial neck pain only (no radicular or myelopathy symptoms); * Has been previously diagnosed with osteopenia or osteomalacia; * Has any of the following that may be associated with a diagnosis of osteoporosis (if Yes to any of the below risk factors, a DEXA Scan will be required to determine eligibility): * Postmenopausal non-black female over 60 years of age who weighs less than 140 pounds; * Postmenopausal female who has sustained a non-traumatic hip, spine, or wrist fracture; * Male over the age of 70; * Male over the age of 60 who has sustained a non-traumatic hip or spine fracture. * If the level of bone mineral density is a T score of -1.5 or lower (i.e., -1.6, 1.7, etc.), then the patient is excluded from the study * Has presence of spinal metastases; * Has overt or active bacterial infection, either local or systemic; * Has insulin-dependent diabetes; * Has chronic or acute renal failure or prior history of renal disease; * Known PEEK, ceramic, titanium allergy; * Is mentally incompetent (if questionable, obtain psychiatric consult); * Is a prisoner; * Is pregnant; * Is currently an alcohol and/or drug abuser or currently undergoing treatment for alcohol and/or drug abuse; * Is involved with current or pending litigation regarding a spinal condition; * Has received drugs that may interfere with bone metabolism within two weeks prior to the planned date of spinal surgery (e.g., steroids or methotrexate), excluding routine perioperative anti-inflammatory drugs; * Has a history of an endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's Disease, renal osteodystrophy, Ehlers-Danlos Syndrome, or osteogenesis imperfecta); * Has a condition that requires postoperative medications that interfere with the stability of the implant, such as steroids. (This does not include low-dose aspirin for prophylactic anticoagulation and routine perioperative anti-inflammatory drugs); * Has received treatment with an investigational therapy within 28 days prior to implantation surgery or such treatment is planned during the 16 weeks following implantation.

Design outcomes

Primary

MeasureTime frameDescription
Composite Clinical Success (CCS) Rate of the Simplify® Disc24 MonthsIndividual success is defined as at least a 15 point improvement in Neck Disability Index (NDI) Score at 24 months compared with baseline, maintenance or improvement in neurologic status at 24 months compared with baseline, no additional surgical procedure at the index level within 24 months, and the absence of a serious adverse event classified as implant-associated or implant/surgical procedure-associated within 24 months. NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.

Secondary

MeasureTime frameDescription
Number of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)Baseline, 3mosTime to recovery is defined as time to first 15-point improvement in NDI NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.
Neck Pain Intensity QuestionnaireBaseline, 24mos.Changes of at least 2 points on a 10-point scale will be regarded as clinically significant (0=no pain; 10=worst pain)
Arm Pain Intensity QuestionnaireBaseline, 24mos.Changes of at least 2 points on a 10-point scale will be regarded as clinically significant (0=no pain; 10=worst pain)
Patient Questionnaires- Treatment Satisfaction SurveyBaseline, 24mos.Question 1 - I am satisfied with the results of my surgery was compared between groups at Month 24. Answer options ranged from definitely true to definitely false.
SF-36v2 Health Survey Physical Component Score (PCS) Maintenance or ImprovementBaseline, 24mosThe PCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as PCS(Postop) - PCS(Preop) ≥0.
SF-36 Mental Component Score (MCS) Maintenance or ImprovementBaseline, 24mos.The MCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as MCS(Postop) - MCS(Preop) ≥0.
Dysphagia Handicap Index (DHI)Baseline, 24mos.Dysphagia Handicap Index (DHI scale) for the investigational Simplify® Disc at 24 months compared to baseline. A higher score is indicative of a less desirable outcome. It is scored 0-100. Data was not collected on DHI in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
Neurological StatusBaseline, 24mosNeurological success was defined as maintenance or improvement in neurologic status at Month 24 as compared to baseline, as determined by the independent Clinical Events Committee (CEC). The CEC reviews neurological exams of motor, sensory, reflex, and myelopathic gait to make an adjudication determination.
Change in Average Disc Height (Superior Index Level)Baseline, 24mos.Average disc height (superior index level) at 24 months was compared to the baseline measurement and the change was calculated. Measurements were scored by an independent core lab. Average disc height is calculated as the simple average of the anterior and posterior disc heights. Data was not collected on disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
Change in Average Disc Height (Inferior Index Level)Baseline, 24MAverage disc height (inferior index level) at 24 months was compared to the baseline measurement and the change was calculated. Measurements were scored by an independent core lab. Average disc height is calculated as the simple average of the anterior and posterior disc heights. Data was not collected on disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
Superior Adjacent Level Disc Degeneration (ALDD)Baseline, 24mos.Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) above the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space), indeterminate, or unable to assess. Data was not collected on ALDD in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
Inferior Adjacent Level Disc Degeneration (ALDD)Baseline, 24mos.Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) below the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space), indeterminate, or unable to assess. Data was not collected on ALDD in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.
Facet Degeneration (Superior Index Level)Baseline, 24mos.Facet degeneration was assessed using MRI for the investigational Simplify Disc at 24 months compared to baseline. Degeneration was graded as none (normal facet joint space), mild (narrowing of the facet joint space and / or small osteophytes and / or mild hypertrophy of the articular process), moderate (narrowing of the facet joint space and/or moderate osteophytes and/or moderate hypertrophy of the articular process and / or mild subarticular bone erosions), severe (Narrowing of the facet joint space and/or large osteophytes and/or severe hypertrophy of the articular process and/or severe subarticular bone erosions and/or subchondral cysts), indeterminate, or unable to assess. Facet degeneration was not assessed in the ACDF historical control group, as there is no 24 month MRI. This was pre-specified in the study design.
Facet Degeneration (Inferior Index Level)Baseline, 24mos.Facet degeneration was assessed using MRI for the investigational Simplify Disc at 24 months compared to baseline. Degeneration was graded as none (normal facet joint space), mild (narrowing of the facet joint space and / or small osteophytes and / or mild hypertrophy of the articular process), moderate (narrowing of the facet joint space and/or moderate osteophytes and/or moderate hypertrophy of the articular process and / or mild subarticular bone erosions), severe (Narrowing of the facet joint space and/or large osteophytes and/or severe hypertrophy of the articular process and/or severe subarticular bone erosions and/or subchondral cysts), indeterminate, or unable to assess. Facet degeneration was not assessed in the ACDF historical control group, as there is no 24 month MRI. This was pre-specified in the study design.
Physician's Perception of ResultsBaseline, 24mos.Results at 24 months for the investigational Simplify® Disc and at 24 months for the control ACDF will also be categorized by the physician according to their perception of the results. Available responses include excellent, good, fair, and poor. Maintenance or improvement was defined as either maintenance of the assigned preoperative grade or any shift to a more favorable grade postoperatively (e.g. poor to fair, fair to good).

Countries

United States

Participant flow

Pre-assignment details

Historical control was used for control arm. The only subjects enrolled under this study were investigational subjects (Simplify Disc).

Participants by arm

ArmCount
Simplify Disc
Simplify Disc at two levels of the cervical spine Simplify Disc: Simplify Disc at two levels of the cervical spine
182
Historical Control
This study will utilize a non-concurrent historical control with subject-level data on a parallel group design. The historical control group will be formed from the randomized ACDF arm of a previously completed two level cervical disc trial.
170
Total352

Baseline characteristics

CharacteristicHistorical ControlTotalSimplify Disc
Age, Continuous47.45 years
STANDARD_DEVIATION 7.89
48.38 years
STANDARD_DEVIATION 8.7
49.25 years
STANDARD_DEVIATION 9.39
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
177 Participants177 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants4 Participants1 Participants
Race (NIH/OMB)
Black or African American
6 Participants12 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants9 Participants5 Participants
Race (NIH/OMB)
White
157 Participants327 Participants170 Participants
Region of Enrollment
United States
170 participants352 participants182 participants
Sex: Female, Male
Female
89 Participants184 Participants95 Participants
Sex: Female, Male
Male
81 Participants168 Participants87 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 1821 / 170
other
Total, other adverse events
96 / 182145 / 170
serious
Total, serious adverse events
32 / 18262 / 170

Outcome results

Primary

Composite Clinical Success (CCS) Rate of the Simplify® Disc

Individual success is defined as at least a 15 point improvement in Neck Disability Index (NDI) Score at 24 months compared with baseline, maintenance or improvement in neurologic status at 24 months compared with baseline, no additional surgical procedure at the index level within 24 months, and the absence of a serious adverse event classified as implant-associated or implant/surgical procedure-associated within 24 months. NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.

Time frame: 24 Months

Population: While 168 Simplify Disc subjects and 127 historical control subjects were considered completers for subject accounting purposes, 173 (Simplify Disc) and 145 (ACDF) subjects were evaluable for composite clinical success. This is due to the fact that some subjects were known failures prior to the 24-month visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Simplify DiscComposite Clinical Success (CCS) Rate of the Simplify® Disc153 Participants
Historical ControlComposite Clinical Success (CCS) Rate of the Simplify® Disc105 Participants
p-value: 0.017t-test, 1 sided
Secondary

Arm Pain Intensity Questionnaire

Changes of at least 2 points on a 10-point scale will be regarded as clinically significant (0=no pain; 10=worst pain)

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 158 Simplify Disc subjects had change in Arm Pain Intensity data at 24 months due to missed questionnaires.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscArm Pain Intensity QuestionnaireSuccess142 Participants
Simplify DiscArm Pain Intensity QuestionnaireFailure16 Participants
Historical ControlArm Pain Intensity QuestionnaireSuccess108 Participants
Historical ControlArm Pain Intensity QuestionnaireFailure19 Participants
Secondary

Change in Average Disc Height (Inferior Index Level)

Average disc height (inferior index level) at 24 months was compared to the baseline measurement and the change was calculated. Measurements were scored by an independent core lab. Average disc height is calculated as the simple average of the anterior and posterior disc heights. Data was not collected on disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.

Time frame: Baseline, 24M

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 157 Simplify Disc subjects had evaluable radiographs for this assessment at 24 months due to missed x-rays or poor image quality which limited analysis.

ArmMeasureValue (MEAN)Dispersion
Simplify DiscChange in Average Disc Height (Inferior Index Level)0.84 mmStandard Deviation 0.96
Secondary

Change in Average Disc Height (Superior Index Level)

Average disc height (superior index level) at 24 months was compared to the baseline measurement and the change was calculated. Measurements were scored by an independent core lab. Average disc height is calculated as the simple average of the anterior and posterior disc heights. Data was not collected on disc height in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 164 Simplify Disc subjects had evaluable radiographs for this assessment at 24 months due to missed x-rays or poor image quality which limited analysis.

ArmMeasureValue (MEAN)Dispersion
Simplify DiscChange in Average Disc Height (Superior Index Level)1.19 mmStandard Deviation 0.81
Secondary

Dysphagia Handicap Index (DHI)

Dysphagia Handicap Index (DHI scale) for the investigational Simplify® Disc at 24 months compared to baseline. A higher score is indicative of a less desirable outcome. It is scored 0-100. Data was not collected on DHI in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

ArmMeasureValue (MEAN)Dispersion
Simplify DiscDysphagia Handicap Index (DHI)6.9 score on a scaleStandard Deviation 10.7
Secondary

Facet Degeneration (Inferior Index Level)

Facet degeneration was assessed using MRI for the investigational Simplify Disc at 24 months compared to baseline. Degeneration was graded as none (normal facet joint space), mild (narrowing of the facet joint space and / or small osteophytes and / or mild hypertrophy of the articular process), moderate (narrowing of the facet joint space and/or moderate osteophytes and/or moderate hypertrophy of the articular process and / or mild subarticular bone erosions), severe (Narrowing of the facet joint space and/or large osteophytes and/or severe hypertrophy of the articular process and/or severe subarticular bone erosions and/or subchondral cysts), indeterminate, or unable to assess. Facet degeneration was not assessed in the ACDF historical control group, as there is no 24 month MRI. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 166 Simplify Disc subjects had an evaluable MRI for this assessment at 24 months due to missed MRIs.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscFacet Degeneration (Inferior Index Level)None96 Participants
Simplify DiscFacet Degeneration (Inferior Index Level)Mild60 Participants
Simplify DiscFacet Degeneration (Inferior Index Level)Moderate8 Participants
Simplify DiscFacet Degeneration (Inferior Index Level)Severe0 Participants
Simplify DiscFacet Degeneration (Inferior Index Level)Indeterminate0 Participants
Simplify DiscFacet Degeneration (Inferior Index Level)Unable to assess2 Participants
Secondary

Facet Degeneration (Superior Index Level)

Facet degeneration was assessed using MRI for the investigational Simplify Disc at 24 months compared to baseline. Degeneration was graded as none (normal facet joint space), mild (narrowing of the facet joint space and / or small osteophytes and / or mild hypertrophy of the articular process), moderate (narrowing of the facet joint space and/or moderate osteophytes and/or moderate hypertrophy of the articular process and / or mild subarticular bone erosions), severe (Narrowing of the facet joint space and/or large osteophytes and/or severe hypertrophy of the articular process and/or severe subarticular bone erosions and/or subchondral cysts), indeterminate, or unable to assess. Facet degeneration was not assessed in the ACDF historical control group, as there is no 24 month MRI. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 166 Simplify Disc subjects had an evaluable MRI for this assessment at 24 months due to missed MRIs.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscFacet Degeneration (Superior Index Level)None87 Participants
Simplify DiscFacet Degeneration (Superior Index Level)Mild64 Participants
Simplify DiscFacet Degeneration (Superior Index Level)Moderate13 Participants
Simplify DiscFacet Degeneration (Superior Index Level)Severe0 Participants
Simplify DiscFacet Degeneration (Superior Index Level)Indeterminate0 Participants
Simplify DiscFacet Degeneration (Superior Index Level)Unable to assess2 Participants
Secondary

Inferior Adjacent Level Disc Degeneration (ALDD)

Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) below the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space), indeterminate, or unable to assess. Data was not collected on ALDD in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 166 Simplify Disc subjects had evaluable radiographs for this assessment at 24 months due to missed x-rays or poor image quality which limited analysis.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)None110 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Doubtful20 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Minimal9 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Moderate2 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Severe1 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Indeterminate21 Participants
Simplify DiscInferior Adjacent Level Disc Degeneration (ALDD)Unable to assess3 Participants
Secondary

Neck Pain Intensity Questionnaire

Changes of at least 2 points on a 10-point scale will be regarded as clinically significant (0=no pain; 10=worst pain)

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 158 Simplify Disc subjects had change in Neck Pain Intensity data at 24 months due to missed questionnaires.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscNeck Pain Intensity QuestionnaireSuccess147 Participants
Simplify DiscNeck Pain Intensity QuestionnaireFail11 Participants
Historical ControlNeck Pain Intensity QuestionnaireSuccess110 Participants
Historical ControlNeck Pain Intensity QuestionnaireFail17 Participants
Secondary

Neurological Status

Neurological success was defined as maintenance or improvement in neurologic status at Month 24 as compared to baseline, as determined by the independent Clinical Events Committee (CEC). The CEC reviews neurological exams of motor, sensory, reflex, and myelopathic gait to make an adjudication determination.

Time frame: Baseline, 24mos

Population: While 127 historical control subjects were considered completers for subject accounting purposes, 128 historical subjects had sufficient neurological data available for CEC determination of maintenance or improvement of neurological status.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscNeurological StatusDeteriorated0 Participants
Simplify DiscNeurological StatusImproved140 Participants
Simplify DiscNeurological StatusMaintained28 Participants
Historical ControlNeurological StatusMaintained19 Participants
Historical ControlNeurological StatusDeteriorated3 Participants
Historical ControlNeurological StatusImproved106 Participants
Secondary

Number of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)

Time to recovery is defined as time to first 15-point improvement in NDI NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.

Time frame: Baseline, 3mos

Population: While 168 Simplify Disc subjects and 127 historical control subjects were considered completers for subject accounting purposes at 24 months, 177 (Simplify Disc) and 154 (ACDF) subjects had evaluable change in NDI scores at 3 months.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscNumber of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)15-Point Improvement (Yes)160 Participants
Simplify DiscNumber of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)15-Point Improvement (No)17 Participants
Historical ControlNumber of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)15-Point Improvement (Yes)123 Participants
Historical ControlNumber of Subjects With 15-point Improvement in NDI at 3 Months (Time to Recovery)15-Point Improvement (No)31 Participants
Secondary

Patient Questionnaires- Treatment Satisfaction Survey

Question 1 - I am satisfied with the results of my surgery was compared between groups at Month 24. Answer options ranged from definitely true to definitely false.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects and 127 historical control subjects were considered completers for subject accounting purposes, 172 (Simplify Disc) and 145 (ACDF) subjects had evaluable treatment satisfaction data at 24 months.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscPatient Questionnaires- Treatment Satisfaction SurveyMostly true26 Participants
Simplify DiscPatient Questionnaires- Treatment Satisfaction SurveyMostly false5 Participants
Simplify DiscPatient Questionnaires- Treatment Satisfaction SurveyDon't know8 Participants
Simplify DiscPatient Questionnaires- Treatment Satisfaction SurveyDefinitely false2 Participants
Simplify DiscPatient Questionnaires- Treatment Satisfaction SurveyDefinitely true131 Participants
Historical ControlPatient Questionnaires- Treatment Satisfaction SurveyDefinitely false5 Participants
Historical ControlPatient Questionnaires- Treatment Satisfaction SurveyDefinitely true99 Participants
Historical ControlPatient Questionnaires- Treatment Satisfaction SurveyMostly true30 Participants
Historical ControlPatient Questionnaires- Treatment Satisfaction SurveyDon't know7 Participants
Historical ControlPatient Questionnaires- Treatment Satisfaction SurveyMostly false4 Participants
Secondary

Physician's Perception of Results

Results at 24 months for the investigational Simplify® Disc and at 24 months for the control ACDF will also be categorized by the physician according to their perception of the results. Available responses include excellent, good, fair, and poor. Maintenance or improvement was defined as either maintenance of the assigned preoperative grade or any shift to a more favorable grade postoperatively (e.g. poor to fair, fair to good).

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects and 127 historical control subjects were considered completers for subject accounting purposes, 170 (Simplify Disc) and 145 (ACDF) subjects had evaluable Physician's Perception of Results data at 24 months.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscPhysician's Perception of ResultsExcellent139 Participants
Simplify DiscPhysician's Perception of ResultsGood26 Participants
Simplify DiscPhysician's Perception of ResultsFair3 Participants
Simplify DiscPhysician's Perception of ResultsPoor2 Participants
Historical ControlPhysician's Perception of ResultsPoor3 Participants
Historical ControlPhysician's Perception of ResultsExcellent85 Participants
Historical ControlPhysician's Perception of ResultsFair15 Participants
Historical ControlPhysician's Perception of ResultsGood42 Participants
Secondary

SF-36 Mental Component Score (MCS) Maintenance or Improvement

The MCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as MCS(Postop) - MCS(Preop) ≥0.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 158 Simplify Disc subjects had SF-36 data available at 24 months due to missed questionnaires.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscSF-36 Mental Component Score (MCS) Maintenance or ImprovementMaintenance or improvement125 Participants
Simplify DiscSF-36 Mental Component Score (MCS) Maintenance or ImprovementAbsence of maintenance or improvement33 Participants
Historical ControlSF-36 Mental Component Score (MCS) Maintenance or ImprovementMaintenance or improvement94 Participants
Historical ControlSF-36 Mental Component Score (MCS) Maintenance or ImprovementAbsence of maintenance or improvement33 Participants
Secondary

SF-36v2 Health Survey Physical Component Score (PCS) Maintenance or Improvement

The PCS is a sub-score of the SF-36. The SF-36 is a multipurpose survey with 36 questions. The questions were combined, scored, and weighted to create two scores that provide glimpses into mental and physical functioning and overall health-related quality-of-life. Higher scores indicate better outcomes. Scores range from 0-50. Maintenance or improvement was defined as PCS(Postop) - PCS(Preop) ≥0.

Time frame: Baseline, 24mos

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 158 Simplify Disc subjects had SF-36 data available at 24 months due to missed questionnaires.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscSF-36v2 Health Survey Physical Component Score (PCS) Maintenance or ImprovementMaintenance or improvement146 Participants
Simplify DiscSF-36v2 Health Survey Physical Component Score (PCS) Maintenance or ImprovementAbsence of maintenance or improvement12 Participants
Historical ControlSF-36v2 Health Survey Physical Component Score (PCS) Maintenance or ImprovementMaintenance or improvement114 Participants
Historical ControlSF-36v2 Health Survey Physical Component Score (PCS) Maintenance or ImprovementAbsence of maintenance or improvement13 Participants
Secondary

Superior Adjacent Level Disc Degeneration (ALDD)

Outcome reports the number and percentage of subjects with adjacent level disc degeneration (ALDD) above the index level based on X-ray images. Degeneration was graded as none (no degenerative changes), doubtful (Minimal osteophytosis only), minimal (Definite osteophytosis with some sclerosis of anterior part of vertebral plates), moderate (Marked osteophytosis and sclerosis of vertebral plates with slight narrowing of disk space), severe (Large osteophytes, marked sclerosis of vertebral plates, and marked narrowing of disk space), indeterminate, or unable to assess. Data was not collected on ALDD in the historical ACDF control group. Only Simplify Disc subjects are reported. This was pre-specified in the study design.

Time frame: Baseline, 24mos.

Population: While 168 Simplify Disc subjects were considered completers for subject accounting purposes, 166 Simplify Disc subjects had evaluable radiographs for this assessment at 24 months due to missed x-rays or poor image quality which limited analysis.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)None100 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Doubtful45 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Minimal16 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Moderate2 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Severe1 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Unable to assess2 Participants
Simplify DiscSuperior Adjacent Level Disc Degeneration (ALDD)Indeterminate0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026